News

Flu vaccine achieves positive results and offers pandemic hope

07-Jan-08

An influenza vaccine that could help to protect against a possible flu pandemic has achieved positive results in early trials, say UK researchers.

The vaccine known as ACAM-FLU-A, made by the biotechnology company Acambis, targets all strains of influenza A, the type responsible for a pandemic.

Preliminary results from phase one clinical trials involving 79 volunteers have shown that the vaccine is well tolerated and immunogenic.

In a parallel study, the researchers also tested whether the vaccine could offer protection against avian flu.

Using ferrets, which are commonly used in flu research because they are susceptible to human and bird flu, they found that 70 per cent of those that were vaccinated were protected against the H5N1 virus.

sanjay.tanday@haymarket.com

Comment below and tell us what you think 

See all commented articles in our Forums and Blogs section  

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Quick search - use * for an abbreviated search, eg nico*

 
 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs